Skip to content
Sistemic Ltd logo — MicroRNA-based services for advanced cell therapy characteri...

Sistemic Ltd

MicroRNA-based services for advanced cell therapy characterization

Founded 2009 United Kingdom Glasgow, United Kingdom 8 employees Series A Total: $1.00M Biotechnology, Health Care +1

General Information

Company Name Sistemic Ltd
Founded Year 2009
Location United Kingdom Glasgow, United Kingdom
Employees 8
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Business Model B2B, DaaS, B2D
Revenue Model Service Fee, Licensing, Data Monetization
Social

BounceWatch is an independent company data service, not affiliated with Sistemic Ltd. To contact Sistemic Ltd, visit sistemic.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sistemic Ltd compare?

A PDF of Sistemic Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sistemic Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sistemic Ltd

Sistemic Ltd, founded in 2009 and headquartered in the United Kingdom, pioneers in integrating microRNA (miRNA) for advanced cell therapy characterization. The company's slogan, "MicroRNA-based services for advanced cell therapy characterization," succinctly encapsulates its mission. Sistemic operates within the vital sectors of Biotechnology, Health Care, and Pharmaceutical markets.

By focusing on miRNA's potential as "master controllers of a cell," the firm delivers a systems approach through its proprietary Sistemic Methodology. This includes robust miRNA profiling, superior statistical analytics, and multi-layered contextual analysis—yielding knowledge-rich data indicative of broad biological effects rather than isolated pathways.

The company's most recent investment was a $1.00M Series A round in March 2010, led by Chimera Bioengineering. As such, Sistemic Ltd presents an intriguing prospect for investors focused on innovative, data-rich solutions in the biopharmaceutical landscape.

Business keywords: microRNA-based services, cell therapy characterization, bioprocessing, stem cell therapy, drug discovery and development, quality control for cells, toxicity studies, drug response products, miRNA profiling, statistical analytics, contextual analysis, biological changes analysis, drug repositioning, compounds discovery technology, biomarkers development

Services & Products

microRNA-based assays
batch release assay
mycoplasma detection
drug repositioning & re-purposing
quality control for cell therapies
predictive toxicology

Target Customers

Pharmaceutical companies Biotechnology firms Cell and Gene Therapy developers Research and Development laboratories

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $1.00M 1
Chimera Bioengineering
01 Mar 2010

Sistemic Ltd Alternatives & Competitors

View All Alternatives
Sistemic Ltd vs
ValitaCell
ValitaCell Ireland

We create pioneering analytical technologies for quality control and performance for the biopharmace...

Grant
6 employees
Biotechnology, Health Care
Sistemic Ltd vs

Together, We Create Healthier Lives

IPO
14325 employees
Biotechnology, Health Care
Sistemic Ltd vs

Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines...

Seed
38 employees
Biotechnology, Life Sciences

FAQ About Sistemic Ltd

MicroRNA-based services for advanced cell therapy characterization
Sistemic Ltd was founded in 2009.
Sistemic Ltd is headquartered in Glasgow, United Kingdom.
Sistemic Ltd operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on microRNA-based services, cell therapy characterization, bioprocessing and stem cell therapy. Its customers include Pharmaceutical companies, Biotechnology firms and Cell and Gene Therapy developers.
Sistemic Ltd has a B2B, DaaS and B2D business model. Its revenue comes from Service Fee, Licensing and Data Monetization.
Sistemic Ltd has approximately 8 employees.
Sistemic Ltd has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Series A.
Sistemic Ltd offers: microRNA-based assays, batch release assay, mycoplasma detection, drug repositioning & re-purposing, quality control for cell therapies, predictive toxicology.
Top alternatives and competitors to Sistemic Ltd include ValitaCell, Charles River Laboratories, Noble Life Sciences Inc, Tango Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sistemic Ltd and ValitaCell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sistemic Ltd, https://bouncewatch.com/company/sistemic-ltd, updated 23 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout